Management of angiotensin-converting enzyme inhibitor-related angioedema: Recommendations from the French national centre for angioedema;Prise en charge des angiœdèmes induits par les inhibiteurs de l'enzyme de conversion de l'angiotensine : Recommandations du Centre de référence national des angiœdèmes

Revue de Medecine Interne

Volumn 34, Issue 4, 2013, Pages 209-213

  Nosbaum, A ^a   Bouillet, L ^b   Floccard, B ^c   Javaud, N ^d,e   Launay, D ^f   Boccon Gibod, I ^b   Fain, O ^g  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d HÔPITAL JEAN VERDIER   (France)

^e AVICENNE HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ PARIS 13   (France)

Author keywords

Angioedema; Angiotensin converting enzyme inhibitors; Bradykinin; Consensus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIONEUROTIC EDEMA; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG SURVEILLANCE PROGRAM; HUMAN; MANAGED CARE; PATIENT CARE; SHORT SURVEY; STANDARDIZATION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOEDEMA; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FRANCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RECEPTORS, BRADYKININ;

EID: 84875813901     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.12.017     Document Type: Short Survey

References (26)

1. Bouillet L. Bradykinin mediated laryngeal oedema due to angiotensin converting enzyme inhibitor. Rev Fr Allergol 2012, 52:157-159.
2. Miller D., Oliveria S., Berlowitz D., Fincke B., Stang P., Lillienfeld D. Angioedema incidence in US veterans initiating angiotensin converting enzyme inhibitors. Hypertension 2008, 51:1-2.
3. Makani H., Messerli F.H., Romero J., Wever-Pinzon O., Korniyenko A., Berrios R.S., et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 2012, 110:383-391.
4. Roberts J., Lee J., Marthers D. Angiotensin-converting enzyme (ACE) inhibitor Angioedema: the silent epidemic. Am J Cardiol 2012, 109:774-777.
5. Hoover T., Lippmann M., Grouzmann E., Marceau F., Herscu P. Angiotensin converting enzyme inhibitor-induced angioedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 2009, 103:502-507.
6. Cicardi M., Cicardi M., Zingale L.C., Bergamaschini L., Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004, 164:910-913.
7. Weber M., Messerli F. Angiotensin converting enzyme inhibitors and angioedema estimating the risk. Hypertension 2008, 51:1465-1467.
8. Agostoni A., Cicardi M., Cugno M., Zingale L., Gioffre D., Nussberger J. Angioedema due to angiotensin converting enzyme inhibitors. Immunopharmacol 1999, 44:21-25.
9. Bouillet L., Boccon-Gibod I., Massot C. Les angiœdèmes bradykiniques héréditaires ou acquis. Rev Med Interne 2011, 32:225-231.
10. Bouillet L. L'angiœdème héréditaire : une révolution thérapeutique. Rev Med Interne 2012, 33:150-154.
11. Caballero T., Baeza M.L., Cabañas R., Campos A., Cimbollek S., Gómez-Traseira C., et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. J Investig Allergol Clin Immunol 2011, 21:422-441.
12. Guide d'analyse de la littérature et graduation des recommandations ANAES, 2010.
13. Clark W., Mucklow J. Gathering and weighing the evidence. Medicines Management 1998, BMJ Books and Pharmaceutical Press, London. R. Panton, S. Chapman (Eds.).
14. Beltrami L., Zanichelli A., Zingale L., Vacchinib R., Carugo S., Cicardi M. Long-term follow-up of 111 patients with angiotensin converting enzyme inhibitor-related angioedema. J Hypertension 2011, 29:2273-2277.
15. Kostis J., Packer M., Black H., Schmieder R., Henry D., Levy E. Omapatrilat and enalapril in patients with hypertension: the omapatrilat cardiovascular treatment vs. enalapril (OCTAVE) trial. Am J Hypertens 2004, 17:103-111.
16. Brown N., Byiers S., Carr D., Maldonado M., Warner B. Dipeptidyl peptidase IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 2009, 54:516-523.
17. Duerr M., Glander P., Diekmann F., Dragun D., Neumayer H., Budde K. Increased Incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients. Clin J Am Soc Nephrol 2010, 5:703-708.
18. Banerji A., Clark S., Blanda M., LoVecchio F., Snyder B., Camargo C.A. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008, 100:327-332.
19. Schmidt P.W., Hirschl M.M., Trautinger F. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. J Am Acad Dermatol 2010, 63:913-914.
20. Bas M., Greve J., Stelter K., Bier H., Stark T., Hoffmann T., et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin converting enzyme inhibitors: a case series. Ann Emerg Med 2010, 56:278-282.
21. Gelée B., Michel P., Haas P., Boishardy F. Angiotensin converting enzyme inhibitor-related angioedema: treatment in an emergency room with complement C1 inhibitor concentrate. Rev Med Intern 2007, 29:516-519.
22. Nielsen E.W., Gramstad S. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 2006, 50:120-122.
23. Beltrami L., Zingale L.C., Carugo S., Cicardi M. Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it. Expert Opin Drug Saf 2006, 5:643-649.
24. Haymore B.R., Yoon J., Mikita C.P., Klote M.M., DeZee K.J. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol 2008, 101:495-499.
25. Beavers C.J., Dunn S.P., Macaulay T.E. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Ann Pharmacother 2011, 45:520-524.
26. Toh S., Reichman M., Houstoun M., Southworth M.R., Ding X., Hernandez A., et al. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med 2012, 172:1582-1589.